Acorda Therapeutics Shares Trading Premarket Following Effect Of 1:20 Reverse Stock Split
Portfolio Pulse from Charles Gross
Acorda Therapeutics has implemented a 1:20 reverse stock split, causing its shares to trade premarket.

June 05, 2023 | 10:44 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Acorda Therapeutics' shares are trading premarket following a 1:20 reverse stock split.
The reverse stock split will reduce the number of outstanding shares, which may lead to a higher stock price. However, the overall market value of the company remains unchanged. The short-term impact on the stock price is uncertain, as the market may react positively or negatively to the reverse split.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100